<b>Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma</b><b> cells </b>-Reference-Cited by-同舟云学术

Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells

Published:2019-02-01 Issue:1 Volume:40 Page:37-49
ISSN:0388-6107
Container-title:Biomedical Research
language:en
Short-container-title:Biomed. Res.

Author:

NAKAZAWA Seitaro¹,SAKATA Ken-ichiro²,LIANG Shanshan³,YOSHIKAWA Kazuhito²,IIZASA Hisashi⁴,TADA Mitsuhiro⁵,HAMADA Jun-ichi⁶,KASHIWAZAKI Haruhiko⁷,KITAGAWA Yoshimasa²,YAMAZAKI Yutaka¹

Affiliation:

1. Department of Gerodontology, Division of Oral Health Science, Graduate School of Dental Medicine

2. Department of Oral Diagnosis and Oral Medicine, Division of Oral Pathobiological Science, Graduate School of Dental Medicine

3. The Key Laboratory of Biomarker High Throughput-Screening and Target Translation of Breast and Gastrointestinal Tumor, Oncology department of Affiliated Zhongshan Hospital of Dalian University

4. Department of Microbiology, Shimane University Faculty of Medicine

5. Department of Neurosurgery, Rumoi Municipal Hospital

6. Health Sciences University of Hokkaido, School of Nursing and Social Services

7. Section of Geriatric Dentistry and Perioperative Medicine in Dentistry, Division of Maxillofacial Diagnostic and Surgical Sciences Faculty of Dental Science

Publisher

Biomedical Research Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/biomedres/40/1/40_37/_pdf

Reference13 articles.

1. 1 Albrecht-Buehler G (1977) The phagokinetic tracks of 3T3 cells. Cell 11, 395–404.

2. 2 Frazier MW, He X, Wang J, Gu Z, Cleaveland JL and Zambetti GP (1998) Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain. Mol Cell Biol 18, 3735–3743.

3. 3 Hassan, N, Tada M, Hamada J, Kashiwazaki H, Kameyama T, Akhter R, Yamazaki Y, Yano M, Inoue N and Moriuchi T (2008) Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer. Cancer Letter 270, 108–19.

4. 4 Kashiwazaki, H., Tonoki H, Tada M, Chiba I, Shindoh M, Totsuka Y, Iggo R and Moriuchi T (1997) High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay. Oncogene 15, 2667–2674.

5. 5 Lane DP (1992) Cancer. p53, guardian of genome. Nature 358, 15–16.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylation-Based Characterization of a New IDH2 Mutation in Sinonasal Undifferentiated Carcinoma;International Journal of Molecular Sciences;2024-06-13

2. ΔNp63 Regulates Radioresistance in Human Head and Neck Squamous Carcinoma Cells;Current Issues in Molecular Biology;2023-07-27

3. Mutant p53 in head and neck squamous cell carcinoma: Molecular mechanism of gain‑of‑function and targeting therapy (Review);Oncology Reports;2023-07-11

4. Advances in Understanding the Links between Metabolism and Autophagy in Acute Myeloid Leukemia: From Biology to Therapeutic Targeting;Cells;2023-06-05

5. Network analysis reveals miRNA crosstalk between periodontitis and oral squamous cell carcinoma;BMC Oral Health;2023-01-13